Endometrial Polyps Regression With Progesterone Therapy
Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
This prospective randomized study will compare the regression rates of women managed with
watch-and-wait approach and of those treated with 3 cycles of luteal 25mg subcutaneous
progesterone from 18 to 25 days of menstrual cycle